How a syndemic strategy, innovative vaccine delivery, and equity-centered communication transformed the national mpox response into a public health success story.

Strategic analysis across NCCN, ASCO, and ICER methodologies to strengthen guideline positioning, influence payer decisions, and accelerate coverage for an oncology drug's extended indication.

Developing deep market intelligence and competitive landscape analysis to inform strategic decisions for neurology pipeline assets, identifying opportunities and risks across a complex therapeutic area.

Leading the NYC Department of Health's HIV/AIDS prevention and control programs, managing a portfolio of over $250 million across HIV, TB, STD, immunization, and laboratory programs.

A data-driven strategy leveraging real-world evidence, actuarial modeling, and HEOR analytics to optimize drug positioning within the Oncology Care Model's episode-based payment structure.

Providing leadership and oversight of CDC's HIV programs as part of the President's Emergency Plan for AIDS Relief, serving as key health advisor to US Ambassadors on critical public health matters.

Developing and executing integrated launch strategies that align clinical evidence, market access, and commercial positioning to maximize therapeutic impact and commercial success.

A Phase IIa RCT demonstrating how validated PRO measures combined with biomarkers can enhance clinical validation, regulatory credibility, and patient-centric drug development in mental health therapeutics.

Developing and leading corporate philanthropy and social business innovation programs that align business objectives with meaningful health equity outcomes, creating sustainable models for corporate social impact.

Developing a comprehensive patient-reported outcomes and quality of life evidence strategy to support a successful NICE submission for a specialty therapeutic.

Delivering a comprehensive HCP billing and access toolkit under accelerated approval timelines—empowering treatment centers to operationalize a pioneering oncology cell therapy from day one.

An advisory board-driven initiative creating practical workflow tools to streamline the complex patient onboarding journey—from financial clearance through infusion—for cell and gene therapy centers.

How a syndemic strategy, innovative vaccine delivery, and equity-centered communication transformed the national COVID-19 response into a public health success story.

Leading CDC's agency-wide coordination during the largest Ebola outbreak in history, managing interagency collaboration with US government counterparts and international partners across three affected countries.

Building sustainable health infrastructure and local capacity in one of the world's most fragile states, demonstrating that meaningful progress is possible even in the most challenging contexts.

An innovative multi-partner program combining exercise, medication adherence support, and transportation to serve aging individuals with HIV when clinical trial access was disrupted by pandemic restrictions.

A specialized training initiative enhancing the capacity of public health officials to translate research into practical interventions—establishing a scalable model now replicated across Columbia Global Centers.

Developing evidence-based approaches to address the health needs of displaced populations across the Middle East and North Africa, where millions of refugees and migrants face barriers to healthcare access.

How a syndemic strategy, innovative vaccine delivery, and equity-centered communication transformed the national mpox response into a public health success story.